Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.

Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Topical diagnostics methods in primary hyperparathyroidism. Comparative features

Cover Page


Topical diagnostics of parathyroids an important stage in preoperative inspection of patients with a primary hyperparathyreosis. Methods of diagnostics existing for today not always demand use of all methods for each patient. A research problem was studying of diagnostic value of each of research methods separately and their combinations. The obtained data testifies to high sensitivity and specificity of each of methods of preoperative topical diagnostics of a pathology of parathyroids at patients with a primary hyperparathyreosis. Sensitivity of US, the Scintigraphy, US + Scintigraphy and the Multispiral computer tomography (MSCT) has compounded – 96,8 %, 91,8 %, 99,2 % and 95,2 % accordingly. Specificity of US, the Scintigraphy, US+ Scintigraphy and a MSCT has compounded – 91,9 %, 84,2 %, 94,1 % and 94,1 % accordingly. Findings of investigation have taped absence of statistically significant differences in sensitivity and specificity parametres between US and «the gold standard» diagnostics of a pathology of parathyroids that allows to recommend US, as a unique method of primary topical diagnostics of a pathology of parathyroids at a primary hyperparathyreosis. However any doubts in diagnostic accuracy of US demand expansion of all complex of diagnostic actions scintigraphy, including an SPECT, and also MSCT, especially in case of atypical a locating of parathyroids. On the basis of findings of investigation the optimum diagnostic algorithm is developed at a primary hyperparathyreosis.

N S Kuznetsov

Email: ilyakim@yandex.ru

I V Kim

S N Kuznetsov

  1. Hindie E., Ugur O., Fuster D. et al. Parathyroid Task Group of the EANM. 2009 EANM parathyroid guidelines. Eur. J. Nucl. Med. Mol. Imaging 2009; 36: 1201–1216.
  2. Grant C.S., Thompson G., Farley D. et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch. Surg. 2005; 140: 472–478.
  3. Mekel M., Mahajna A., Ish-Shalom S. et al. Minimally invasive surgery for treatment of hyperparathyroidism. Isr. Med. Assoc. J. 2005, 7: 323–327.
  4. Mazzeo S., Caramella D., Lencioni R. et al. Comparison among sonography, doubletracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. Am. J. Roentgenol. 1996; 166: 1465–1470.
  5. Scheiner J.D., Dupuy D.E., Monchik J.M. et al. Preoperative localization of parathyroid adenomas: a comparison of power and colour Doppler ultrasonography with nuclear medicine scintigraphy. Clin. Radiol. 2001; 56: 984–988.
  6. Wakamatsu H., Noguchi S., Yamashita H. et al. Technetium99m tetrofosmin for parathyroid scintigraphy: a direct comparison with 99mTc-MIBI, 201Tl, MRI and US. Eur. J. Nucl. Med. 2001; 28: 1817–1827.
  7. Huppert B.J., Reading C.C. Parathyroid sonography: imaging and intervention. J. Clin. Ultrasound. 2007; 35: 144–155.
  8. Gooding G.A. Sonography of the thyroid and parathyroid. Radiol. Clin. N. Am. 1993; 31: 967–89.
  9. Ulanovski D., Feinmesser R., Cohen M. et al. Preoperative evaluation of patients with parathyroid adenoma: role of highresolution ultrasonography. Head Neck 2002; 24: 1–5.
  10. Crane P., Laliberte R., Heminway S. et al. Effect of mitochondrial viability and metabolism on technetium99m-sestamibi myocardial retention. Eur. J. Nucl. Med. 1993; 20: 20–25.
  11. Mitchell B.K., Cornelius E.A., Zoghbi S. et al. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surgery 1996; 120: 1039–1045.
  12. Kaczirek K., Prager G., Kienast O. et al. Combined transmission and (99m) Tcsestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin 2003; 42: 220–223.
  13. Lorberboym M., Minski I., Macadziob S. et al. Incremental diagnostic value of preoperative 99mTc-MIBI SPECTin patients with a parathyroid adenoma. J. Nucl. Med. 2003; 44: 904–908.
  14. Ansquer C., Mirallie E., Sadot S. et al. Comparison of 99mTcMIBI / 99mTc dual planar scintigraphy, 99mTc-MIBI SPECT and ultrasound in preoperative localization of parathyroid lesions for primary hyperparathyroididsm [abstract]. Eur. J. Nucl. Med. Mol. Imaging 2005; 31: С. 263.
  15. Haber R.S., Kim C.K., Inabnet W.B. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Clin. Endocrinol. (Oxf.) 2002; 57 (2): 241–249.
  16. McDermott V.G., Fernandez R.J., Meakem T.J. et al. Preoperative MR imaging in hyperparathyroidism: results and factors affecting parathyroid detection. Am. J. Roentgenol. 1996; 166: 705–710.
  17. Lee V.S., Spritzer C.E. MR imaging of abnormal parathyroid glands. Am. J. Roentgenol. 1998; 170: 1097–1103.
  18. Gotway M.B., Higgins C.B. MR imaging of the thyroid and parathyroid glands. Magn. Reson. Imaging. Clin. N. Am. 2000; 8: 163–182.
  19. Lo C.Y., Lang B.H., Chan W.F. et al. A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. Am. J. Surg. 2007; 193: 155–159.
  20. Kebapci M., Entok E., Kebapci N. et al. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J. Endocrinol. Invest. 2004; 27: 24–30.
  21. Lumachi F., Marzola M.C., Zuchetta P. et al. Hyperfunctioning parathyroid tumors in patients with thyroid nodules. Sensitivity and positive predictive value of highresolution ultrasonography and 99 mTc sestamibi scintigraphy. Endocr. Relat. Cancer. 2003; 10: 419–423.
  22. Freudenberg L.S., Frilling A., Sheu S.Y. et al. Optimizing preoperative imaging in primary hyperparathyroidism. Langenbecks Arch. Surg. 2006; 391: 551–556.
  23. Krubsack A.J., Wilson S.D., Lawson I.L. et al. Prospective comparison of radionuclide, computed tomographic, sonographic and magnetic resonance localization of parathyroid tumors. Surgery 1989; 106: 639–646.
  24. Kier R., Blinder R.A., Herfkens R.J. et al. MR imaging with surface coils in primary hyperparathyroidism. J. Comput. Assist. Tomogr. 1987; 11: 863–868.
  25. Spritzer C.E., Gefter W.B., Hamilton R. et al. Abnormal parathyroid glands: highresolution MR imaging. Radiology 1987; 162: 487–491.
  26. Kneeland J.B., Krubsack A.J., Lawson T.L. et al. Enlarged parathyroid glands: highresolution local coil MR imaging. Radiology 1987; 162: 143–146.
  27. Ruf J., Lopez Hanninen E., Steinmuller T. et al. Preoperative localization of parathyroid glands. Use of MRI, scintigraphy, and image fusion. Nuklearmedizin 2004; 43: 85–90.
  28. Yao M., Jamieson C., Blend R. Magnetic resonance imaging in preoperative localization of diseased parathyroid glands: a comparison with isotope scanning and ultrasonography. Can. J. Surg. 1993; 36: 241–244.
  29. Lumachi F., Zucchetta P., Marzola M.C. et al. Advantages of combined technetium-99msestamibi scintigraphy and high resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur. J. Endocrinol. 2000; 143: 755–760.
  30. Sukan A., Reyhan M., Aydin M. et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann. Nucl. Med. 2008; 22: 123–131.
  31. De Feo M.L., Colagrande S., Biagini C. et al. Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 2000; 214: 393–402.


Abstract - 904

PDF (Russian) - 531


Copyright (c) 2012 ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.